Laminin, an extracellular matrix molecule (EMM) widely expressed in the basal laminae, interacts with specific membrane receptors among which the integrin molecules are the best known. During embryo development laminin is the first synthesized EMM and plays a significant role in the morphogenesis of organs in which epithelial-mesenchymal interactions and branching take place. The present study describes the distribution of laminin and of β1 integrin receptors during the very early stages of human kidney development. The observations were carried out on paraffin sections of human embryos ranging between the 4th and the 7th gestational week. Laminin was detected within the basement membranes of mesonephric duct, vesicles, glomerular vessels and celomic epithelium. The metanephric anlage reacted with anti-laminin immunoglobulins in the basement membrane underlying the ampullae and in few blastemic cap cells. Low levels of β1 integrin reactivity were found in both the mesonephric and metanephric structures. This study provides for the first time data about the distribution of laminin and β1 integrin in the early stages of human renal organogenesis suggesting a key role for these molecules in the epithelial-mesenchymal interactions necessary for kidney development.

Keywords:
Development, Human kidney, Laminin, β1 Integrin
1.
Engvall E, Wewer UM: Domains of laminin. J Cell Biochem 1996;61:493–501.
2.
Quaranta V, Plopper GE: Integrins and laminins in tissue remodeling. Kidney Int 1997;51:1441–1446.
3.
Cooper AR, MacQueen HA: Subunits of laminin are differentially synthesized on mouse eggs and early embryos. Dev Biol 1983;96:467–471.
4.
Shim C, Kwon HB, Kim K: Differential expression of laminin chain-specific mRNA transcripts during mouse preimplantation embryo development. Mol Reprod Dev 1996;44:44–55.
5.
Mecham RP: Laminin receptor. Annu Rev Cell Biol 1991;7:71–91.
6.
Meredith JE Jr, Winitz S, McArthur Lewis J, Hess S, Ren X-D, Renshaw MW, Schwartz MA: The regulation of growth and intracellular signaling by integrins. Endocr Rev 1996;17:207–220.
7.
Durbeej M, Ekblom P: Dystroglycan and laminins: Glycoconjugates involved in branching epithelial morphogenesis. Exp Lung Res 1997;23:109–118.
8.
Hamilton WJ, Mossman HW: Human Embryology. Cambridge, Heffer, 1976.
9.
Fischer DA, Lakshmanan J: Metabolism and effect of epidermal growth factors and related growth factors in mammals. Endocr Rev 1990;11:418–442.
10.
Rogers S, Ryan G, Hammermann MR: Metanephric transforming growth factor-α is required for renal organogenesis in vitro. Am J Physiol 1992;262:F533–539.
11.
Ekblom M, Klein G, Mugrauer G, Fecker L, Deutzmann R, Timpl R, Ekblom P: Transient and locally restricted expression of laminin A chain mRNA by developing epithelial cells during kidney organogenesis. Cell 1990;60:337–346.
12.
Vanden Heuvel GB, Leardkamolkarn V, St John PL, Abrahamson DR: Carboxy-terminal sequence and synthesis of rat kidney laminin α1 chain. Kidney Int 1996;49:752–760.
13.
Bernardini N, Bianchi F, Lupetti M, Dolfi A: Immunohistochemical localization of the epidermal growth factor, transforming growth factor α, and their receptor in the human mesonephros and metanephros. Dev Dyn 1996;206:231–238.
14.
Kirpatrick P, D’Ardenne AJ: Effects of fixation and enzymatic digestion on the immunohistochemical demonstration of laminin and fibronectin in paraffin-embedded tissue. J Clin Pathol 1984;37:639–644.
15.
Bernardini N, Bianchi F, Lupetti M, Dolfi A: The use of MAB 1977 monoclonal antibody for the immunohistochemical localization of β1 integrins in paraffin-embedded human kidney. Tumori 1997;83:676–681.
16.
Klein G, Langegger M, Timpl R, Ekblom P: Role of laminin A chain in the development of epithelial cell polarity. Cell 1988;55:331–341.
17.
Schuger I, Skubitz APN, O’Shea KS, Chamg JF, Varani J: Identification of laminin domains involved in branching morphogenesis: Effect of anti-laminin monoclonal antibodies on mouse embryonic lung development. Dev Biol 1991;146:531–541.
18.
Kashimata M, Gresik EW: Epidermal growth factor is a physiological regulator of development of the mouse fetal submandibular gland and regulates expression of the α6-integrin subunit. Dev Dyn 1997;208:149–161.
19.
Klinowska TCM, Broomhead G, Streuli CH: Requirement of β1 integrins in the development of mouse mammary gland. Biochem Soc Trans 1996;24:349S.
20.
Whitman M, Melton DA: Growth factors in early embryogenesis. Annu Rev Cell Biol 1989;5:93–117.
21.
Poulsen SS, Nexo E, Olsen PS, Hess J, Kirkegaard P: Immunohistochemical localization of epidermal growth factor in rat and man. Histochemistry 1986;85:389–394.
22.
Partanen AM, Thesleff I: Localization and quantitation 125I-epidermal growth factor binding in mouse embryonic tooth and other embryonic tissues at different development stages. Dev Biol 1987;120:186–197.
23.
Chailler P, Ferrari J, Briere N: Fetal mouse kidney maturation in vitro: Coordinated influences of epidermal growth factor, transferrin and hydrocortisone. Anat Embryol Berl 1991;184:319–329.
24.
Winters TA, Febres FG, Fulgham DL, Bertics PJ, Duello TM, Gorski J: Ontogeny of the epidermal growth factor receptor development of the fetal bovine mesonephros and associated organs of the urogenital tract. Biol Reprod 1993;48:1395–1403.
25.
Schwartz MA: Integrins, oncogenes, and anchorage independence. J Cell Biol 1997;139:575–578.
26.
Mainiero F, Pepe A, Yeon M, Ren Y, Giancotti FG: The intracellular functions of α6β4 integrin are regulated by EGF. J Cell Biol 1996;134:241–253.
27.
Panayotou G, End P, Aumailley M, Timpl R, Engel J: Domains of laminin with growth-factor activity. Cell 1989;56:93–101.
28.
Nelson J, Scott WN, Allen WE, Wilson DJ, Harriott P, McFerran NV, Walker B: Murine epidermal growth factor peptide (33–42) binds to a YIGSR-specific laminin receptor on both tumor and endothelial cells. J Biol Chem 1996;42:26179–26186.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.